SGLT2 inhibitors and diabetic retinopathy progression: evidence from a retrospective cohort study and Mendelian randomization analysis

• by Mengya Wang, Tianwei Liu, Bojun Zhao

• July 16, 2026

Editorial: Community series in: clinical and genetic determinants of diabetes and complications, volume II

• by Kexin Zhang, Maurizio Delvecchio, Xiaodong Sun

• June 12, 2026

Retina Biomarkers for Treatment Selection in DME

• by Kailynn M. Barton, BS, Muhammad Abidi, BS, Rajiv M. Sastry, BA, John B. Miller, MD

• May 1, 2026

• 14 min

GLP-1 RAs Associated With Small ION Risk Increase

In an observational US target trial emulation, glucagon-like peptide-1 receptor agonist initiation was associated with about 3 to 4 more ischemic optic neuropathy cases per 10,000 patients over 18 months than two comparator drug classes.

• by Andrea Surnit

• July 13, 2026

• 5 min